Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers
2001
Journal Article
Authors:
Belshe, R.B.;
Stevens, C.;
Gorse, G.J.;
Buchbinder, S.;
Weinhold, K.;
Sheppard, H.;
Stablein, D.;
Self, S.;
McNamara, J.;
Frey, S.;
Flores, J.;
Excler, J.L.;
Klein, M.;
Habib, R.E.;
Duliege, A.M.;
Harro, C.;
Corey, L.;
Keefer, M.;
Mulligan, M.;
Wright, P.;
Celum, C.;
Judson, F.;
,
Secondary:
J Infec Dis
Volume:
183
Pagination:
1343-52
